Patent · US Active

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

US12059422B2 · kind B2 · utility

0Cited by
16References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2022
Grant dateAug 13, 2024
Priority date—
Expiry dateJun 21, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/1205
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.